11th Circ. Won't Rehear Catalyst's Win In 'Orphan Drug' Case
By Dave Simpson · January 7, 2022, 9:20 PM EST
The Eleventh Circuit declined on Friday a bid to rehear its finding that the U.S. Food and Drug Administration unlawfully infringed on an exclusivity period it awarded Catalyst Pharmaceuticals Inc. for...
To view the full article, register now.